The interim staff report details how increasing vertical integration and concentration has enabled the six largest PBMs to manage nearly 95% of all prescriptions filled in the United States.
DOJ does not expect to take any further actions against Viatris in connection with a civil investigative demand related to the pricing and sales of generic drugs.